Balance Sheet
Accounts PayablesAssetsCash & EquivalentsConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Total Debt: 2021-2024

Historic Total Debt for Abivax (ABVX) over the last 4 years, with Dec 2024 value amounting to $123.4 million.

  • Abivax's Total Debt rose 46.96% to $121.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $121.8 million, marking a year-over-year increase of 46.96%. This contributed to the annual value of $123.4 million for FY2024, which is 48.06% up from last year.
  • Per Abivax's latest filing, its Total Debt stood at $123.4 million for FY2024, which was up 48.06% from $83.3 million recorded in FY2023.
  • Abivax's 5-year Total Debt high stood at $123.4 million for FY2024, and its period low was $13.4 million during FY2021.
  • Its 3-year average for Total Debt is $86.4 million, with a median of $83.3 million in 2023.
  • Data for Abivax's Total Debt shows a peak YoY spiked of 290.91% (in 2022) over the last 5 years.
  • Yearly analysis of 4 years shows Abivax's Total Debt stood at $13.4 million in 2021, then spiked by 290.91% to $52.5 million in 2022, then skyrocketed by 58.80% to $83.3 million in 2023, then soared by 48.06% to $123.4 million in 2024.